Bettani Foods, formerly Climax Foods, has raised $6.5 million in Series A funding to advance its alternative dairy ingredient, Caseed, focusing on allergen- and animal-free solutions for B2B customers.

Target Information

Bettani Foods, previously known as Climax Foods, has successfully secured $6.5 million in Series A funding aimed at advancing innovation in the alternative dairy sector. The funding will primarily support the development of Bettani's proprietary casein ingredient, Caseed, which is both allergen-free and animal-free, specifically catered to B2B customers. Under the leadership of Sandeep Patel, CEO and chairman, Bettani emphasizes creating superior products reflected in their rebranded name—a clever play on the word 'better'.

The company takes a departure from a technology-focused marketing approach, which, according to Patel, can alienate consumers. Instead, Bettani seeks to emphasize flavor and simplicity in its products, aiming to create appealing food items made from natural ingredients that do not evoke the high-tech image often associated with food produced via advanced scientific methods.

Industry Overview

The alternative dairy industry is experiencing significant growth, with rising consumer demand for plant-based products leading to an increase in investment and innovation. This spike in interest is partially driven by growing awareness of dieta